ResearcherVirginia Commonwealth UniversityNo recent work listed

Laurence A. Booth

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113836377. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

The development of multi-kinase inhibitors as pancreatic cancer therapeutics. Co-author DOI 10.1097/cad.0000000000001177 ↗
Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer. Co-author DOI 10.1016/j.bcp.2020.114067 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paul Dent · 2 shared papers, 2020–2021 · strength 0.38
- Paper The development of multi-kinase inhibitors as pancreatic cancer therapeutics. DOI 10.1097/cad.0000000000001177 ↗
- Paper Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer. DOI 10.1016/j.bcp.2020.114067 ↗
John F. Hancock · 1 shared paper, 2021 · strength 0.19
- Paper The development of multi-kinase inhibitors as pancreatic cancer therapeutics. DOI 10.1097/cad.0000000000001177 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.